First Monsanto Roundup® case will go to trial next week

HomeBlogProduct LiabilityFirst Monsanto Roundup® case will go to trial next week

First Monsanto Roundup® case will go to trial next week

June 18, 2018 Categories: Product Liability, Settlements and Lawsuits

First Monsanto Roundup® case will go to trial next week

Lee Johnson, 46-year-old groundskeeper for the school district in Benicia, California, was diagnosed with cancer in 2014 after years of working with Roundup ® weed-killer.

Johnson will be the first among thousands of people across the U.S. to go to trial against Monsanto, blaming Roundup ® herbicide for their disease.

Now, a jury will decide in a case set to start this week in San Francisco state court.

A pretrial ruling allows Johnson’s lawyers to try to use internal Monsanto correspondence to show that the company has long been aware of the risk its herbicides are carcinogenic.

Bloomberg News

Recent Updates

Non-Hodgkin lymphoma patient who was working with Roundup is suing Monsanto

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

July 25, 2018

Gadolinium MRI Poisoning Investigation

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

July 18, 2018

FDA recalls Valsartan – Antihypertensive drug

Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...

July 17, 2018